The goal of MediBeacon’s fluorescent tracer agent-based systems is to provide clinically relevant information that can cost effectively and positively impact patient care.
Accurate physiological measurements made in real-time, are vital in the hospital as well as in the management of chronic diseases. Fluorescent tracer agent-based monitoring systems are being designed to provide an assessment of GFR, quantification of GI permeability, enhanced visualization of the vasculature during ocular angiography, and identification of the ureters during abdominal surgeries.*
MediBeacon products are in various stages of clinical development and are not yet approved for human use.